Skip To Main Content
Sort by

Filtera

Återställ
  • Filtera
  • Innehållstyp
Psychological Considerations During Insulin Product Changes

Psychological Considerations During Insulin Product Changes

Understanding the psychological burden of switching insulin. Discover ways to cope and support patient well-being during treatment changes.

Recognizing the Urgency to proactively plan a switch: Managing Timely Insulin Transitions for Continuity of Care

Recognizing the Urgency to proactively plan a switch: Managing Timely Insulin Transitions for Continuity of Care

Learn why timely insulin transitions are critical for patient safety and continuity of care. Act early to avoid gaps and risks.

 Instruktionsfilm: Praluent Next-gen (75/150/300 mg) - Guide för patienter

Instruktionsfilm: Praluent Next-gen (75/150/300 mg) - Guide för patienter

Breaking the Barrier: How to Manage Hypoglycaemia Fear in Diabetes Care

Breaking the Barrier: How to Manage Hypoglycaemia Fear in Diabetes Care

Reframing the Insulin Conversation: Helping People With Type 2 Diabetes to Embrace Life

Reframing the Insulin Conversation: Helping People With Type 2 Diabetes to Embrace Life

Diabetes och Ramadan

Diabetes och Ramadan

2026 infaller Ramadan mellan 17 februari och 19 mars. Vi har tagit fram material för att hjälpa dig att stötta din patient med diabetes som vill fasta under Ramadan.

Inside Global Fabry Academy (GFA) 2025

Inside Global Fabry Academy (GFA) 2025

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

Om BALANS i Region Stockholm

Om BALANS i Region Stockholm

Bullous Pemphigoid: A Clinical & Scientific Update – A DermTalks Webinar

Bullous Pemphigoid: A Clinical & Scientific Update

FLUNITY-HD Study Demonstrated the<br>Superior Protection Beyond Flu of High-Dose Flu Vaccine vs Standard-Dose Flu Vaccine<sup>*</sup>

FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.

FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1

EVEREST study highlights

EVEREST study: First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma

First ever direct Head-to-Head Comparison of Dupilumab vs Omalizumab in Patients with Severe CRSwNP and Coexisting Asthma.